Access
This article is part of Nature's premium content.
Published online 29 October 2008 | Nature 455, 1168-1170 (2008) | doi:10.1038/4551168a
News Feature
Pharmaceutical futures: Made in China?
Where should the drug industry go to find new ideas? In the first of two features, Alison Abbott asked if the future lies in systems biology -- a field that attempts to piece together 'everything'. In this, the second feature, David Cyranoski looks at drug companies' attraction to China.
From the outside, China may not seem an obvious place to look for a pharmaceutical breakthrough. Last year, the head of the State Food and Drug Agency was executed for taking bribes.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
